Inmune Bio (INMB) Non-Current Assets (2017 - 2026)
Inmune Bio (INMB) reported Non-Current Assets of $3.05 million for Q2 2026, up 84.6% from $1.65 million a year earlier and up 1.7% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Inmune Bio posted Non-Current Assets of $2.46 million, down 85.4% from FY2024.
- Non-Current Assets has declined for four consecutive years, with a five-year compound annual growth rate of -31.8% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $16.9 million in FY2024 (-0.9%), $17.06 million in FY2023 (-0.4%), $17.12 million in FY2022 (-1.3%) and $17.34 million in FY2021 (+4.0%).
- The Q2 2026 figure ranks as the highest quarterly Non-Current Assets since Q1 2025.
- Year over year, Non-Current Assets gained in 1 of the last eight quarters, with an average decline of 32.5%.
- The high point for year-over-year Non-Current Assets in five years was Q2 2026 (growth of 84.6%); the low point was Q2 2025 (a decline of 90.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3 million (Q1 2026), $2.46 million (Q4 2025) and $2.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Inmune Bio | 55.31 Mn | -36.95 Mn | - | 3.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.05 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Sep 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 16.84 Mn |
| Dec 31, 2024 | 16.90 Mn |
| Sep 30, 2024 | 16.93 Mn |
| Jun 30, 2024 | 16.96 Mn |
| Mar 31, 2024 | 17.01 Mn |
| Dec 31, 2023 | 17.06 Mn |
| Sep 30, 2023 | 17.09 Mn |
| Jun 30, 2023 | 17.11 Mn |
| Mar 31, 2023 | 17.10 Mn |
| Dec 31, 2022 | 17.12 Mn |
| Sep 30, 2022 | 17.14 Mn |
| Jun 30, 2022 | 17.26 Mn |
| Mar 31, 2022 | 17.29 Mn |
| Dec 31, 2021 | 17.34 Mn |
| Sep 30, 2021 | 16.74 Mn |
API Access
Inmune Bio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();